Here is an interesting article: "Biolex takes lead drug candidate into phase II trials (BizJournals)"
"Nearly nine months after the company reported a successful phase I trial of lead drug candidate Locteron, Biolex Therapeutics has stepped into a second phase of clinical trials."
Read More
Wednesday, January 31, 2007
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment